News
The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) ...
A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including ...
The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and ...
The U.S. Centers for Disease Control's vaccine advisory committee voted to recommend the single-dose vaccine, Vimkunya, for the prevention chikungunya in 12 years and older traveling to a country ...
Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or ...
A disabling mosquito-borne disease called chikungunya has killed six people in the French Indian Ocean island of La Reunion ...
4d
Pharmaceutical Technology on MSNValneva’s single-dose chikungunya vaccine authorised in BrazilValneva has received marketing authorisation from the Brazilian Health Regulatory Agency (ANVISA) for its single-dose ...
Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...
LONDON — London’s Heathrow Airport said Saturday it has restarted flights after a massive fire caused a pre-dawn power outage Friday at the global transport hub, disrupting travelers around ...
Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...
Health authorities in France's Reunion Island on Friday launched an emergency plan to boost staff in hospitals to deal with the spread of the chikungunya virus. This comes as the Indian Ocean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results